Clinical trial Recruiting at 2 sites Interventional Ages 18 to 75

Improving breathing in patients with cervical spinal cord injuries using neuromodulation

Official title: Neuromodulation to Improve Respiratory Function in Cervical Spinal Cord Injury

Run by University of California, Los Angeles · NCT04883463 · Data updated 2026-11-12

This study is testing if a special device can help people with cervical spinal cord injuries breathe better and reduce their reliance on ventilators.

Quick facts

Study typeInterventional
Ages18 Years to 75 Years
SexAll
Enrollment12 (estimated)
SponsorUniversity of California, Los Angeles
Academic / other
Locations2 sites (Los Angeles, California and 1 other locations)
StatusRecruiting
StartedSeptember 27, 2021
Main results expectedDecember 31, 2027
Study endsDecember 31, 2028
Registry record updatedNovember 6, 2025
Trial IDNCT04883463 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are individuals aged 18-75 with a cervical spinal cord injury at the C2-C7 level, who are at least one year post-injury and have significant respiratory function compromise.

Probably not a fit

Patients with severe autonomic dysreflexia or those who have a phrenic nerve or diaphragm pacer may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study investigates the safety and feasibility of implanting a cervical spinal cord stimulator in individuals with cervical spinal cord injuries who are dependent on mechanical ventilation. The research involves multiple phases, including baseline testing, temporary and permanent implant procedures, and post-implant treatment. Participants will undergo laboratory testing and home training sessions to assess their respiratory function and response to the treatment. The study aims to identify the most responsive subjects who could benefit from this innovative approach.

Why it matters

Potential benefit: If successful, this approach could enhance respiratory function and reduce reliance on mechanical ventilation for patients with cervical spinal cord injuries.

How similar studies have gone: While this approach is innovative, similar studies in neuromodulation for respiratory function have shown promise, indicating potential for success.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Male or female 18-75 years
2. At least 1 year from initial cervical spinal cord injury
3. Non-progressive Spinal Cord Injury (SCI) at C2 - C7 (non-conus injury)
4. Motor Complete ASIA Impairment Scale (A, B, or C)
5. Severe respiratory function compromise requiring dependency on invasive or noninvasive ventilation
6. Able to attend weekly testing sessions for up to 21 months.
7. Have intact chest/lung, upper and lower extremity anatomy. The neuromuscular connections between the spinal cord and its effector muscles (respiratory and extremity) are required to be intact
8. Have intact cognitive ability, able to follow commands/voice concerns, and give consent

Exclusion Criteria:

1. History of severe autonomic dysreflexia
2. Phrenic nerve or diaphragm pacer
3. Phrenic nerve paralysis
4. Musculoskeletal dysfunction, unhealed fracture, pressure ulcer of grade 3 and above in the European Pressure Ulcer Advisory Panel Grading System, active infection
5. Clinically significant depression or ongoing drug abuse as documented in the medical record
6. Received lung surgery within one year prior to study enrollment or has active intrinsic lung disease (e.g. COPD, acute or chronic lung infection, moderate to severe asthma, emphysema, cystic fibrosis, etc.)
7. Cardiopulmonary disease that precludes training or rehabilitation
8. Other implanted stimulation devices
9. Pregnant
10. Severe cardiac disease (e.g. heart failure, atherosclerosis, arrhythmia, stroke, etc.)
11. Subjects involved in other clinical trials not associated with this trial
12. Botox injections in respiratory associated muscles within the last 3 months

Where it's running

  • Semel Institute of Neuroscience at UCLA
    Los Angeles, California, United States
    Recruiting
  • UCLA Clinical and Translational Research Center
    Los Angeles, California, United States
    Recruiting

Study contacts

  • Principal investigator: Daniel C Lu, MD, PhD — University of California, Los Angeles
  • Study coordinator: Daniel C Lu, MD, PhD
  • Email: DCLu@mednet.ucla.edu
  • Phone: 310-267-2975

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.